Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Type 2 Diabetes
-
Age: Between 18 years - 99 years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Subjects who are 18 years of age or older
- Subjects who provide informed consent obtained before any study-related activities.
- Subjects with type 2 diabetes mellitus diagnosis
- Subjects who has been treated with either 1 or 2 oral antidiabetic medications
- Subjects who are current member of an Anthem affiliated commercial health plan with pharmacy benefits
- Subjects who has recorded glycosylated hemoglobin A1c (HbAlc) value within the last 90 days prior to randomization.
- Subjects who are able to Further intensify with an additional anti-diabetic oral or injectable medication is indicated to achieve glycemic target
You may not be eligible for this study if the following are true:
-
- Subjects who had previous randomization in this study
- Subjects who had rreatment with more than 2 oral antidiabetic medications or any injectable medication in a period of 30 days before the day of eligibility assessment.
- Subjects who had contraindications to semaglutide
- Female Subjects who is pregnant, breastfeeding or intends to become pregnant
- Subjects who are participating in another clinical trial
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.